Nutrition 21 Reports Total Revenues of $1.7 Million

Nutrition 21, Inc., the developer and marketer of nutritional ingredients for the dietary supplement and functional food and beverage markets, has announced financial results for its third quarter ended March 31, 2010.

The Company reported total revenues from continuing operations of $1.7 million for the third quarter ended March 31, 2010, compared to $2.0 million in the corresponding quarter a year ago. Net loss from continuing operations for the third quarter this year was $0.7 million, or $(0.01) per diluted common share, compared to a net loss of $1.1 million, or $(0.02) per diluted common share, in the corresponding third quarter a year ago.

For the nine months ended March 31, 2010, the Company reported total revenues from continuing operations of $6.0 million compared to $5.5 million in the comparable period a year ago. Net loss from continuing operations for the nine months ended March 31, 2010 was $1.8 million, or ($0.02) per diluted common share, compared to $3.5 million, or ($0.05) per diluted common share, in the corresponding period a year ago.

The improvement in results is due primarily to the Company's continuing emphasis on expense controls and continued strong sales - primarily chromium picolinate for human consumption.

The Company completed the sale of its retail and direct response businesses during the quarter ended December 31, 2009. Net loss from discontinued operations for the quarter ended March 31, 2010 was $0.1 million, or ($0.00) per diluted common share, compared to a gain of $0.7 million, or $0.1 per diluted common share, in the comparable period a year ago. For the nine months ended March 31, 2010, the Company reported a net loss from discontinued operations of $1.8 million, or ($0.02) per diluted common share, compared to net income of $3.4 million, or $0.5 per diluted common share, in the comparable period a year ago.

Michael Zeher, president and chief executive officer, said, "Our operating Income for the quarter of $0.2 million was 11% of total revenues compared to $52 thousand, or 0% of total revenues, in the comparable period a year ago. For the nine months ended March 31, 2010, our operating income was $1.0 million, or 17% of total revenues, compared to an operating loss of $0.2 million, or negative 3% of total revenues, in the comparable period a year ago. We continue to work on improving both our top-and bottom-lines, and developing new opportunities for our ingredients business."

About Nutrition 21
Nutrition 21, Inc., headquartered in Purchase, NY, is a nutritional bioscience company and holds over 30 issued and pending patents associated with chromium picolinate as well as combinations of chromium compounds with other dietary supplement ingredients. Its ingredients are sold to leading dietary supplement, and functional food and beverage manufacturers and marketers. For more information, visit http://www.nutrition21.com.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish